DRMT - Dermavant Sciences Ltd.

YHD - YHD Delayed Price. Currency in USD
At close: 6:07PM EDT
Stock chart is not supported by your current browser
Previous CloseN/A
YTD ReturnN/A
Expense Ratio (net)N/A
CategoryN/A
Last Cap GainN/A
Morningstar RatingN/A
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (3Y Monthly)N/A
YieldN/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last DividendN/A
Average for CategoryN/A
Inception DateN/A
  • Benzinga

    Dermavant IPO: What You Need To Know

    A dermatology-focused biotech with a lucrative Phase 3 asset is set to price its IPO this week. The IPO Terms Dermavant Sciences is planning to offer 7.7 million shares in an IPO and has indicated a price ...

  • Benzinga

    IPO Outlook For The Week: Biotechs And A Grocery Outlet

    For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . The IPO dates below are expected but not confirmed. Stoke Therapeutics, Inc. (STOK) will issue 6.7 million shares between ...

  • We're sorry this is all we were able to find about this topic.